Crossmark

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

Crossref DOI link: https://doi.org/10.1038/s41467-021-24342-y

Published Online: 2021-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leach, D. A.

Mohr, A.

Giotis, E. S. https://orcid.org/0000-0001-8908-7824
Cil, E. https://orcid.org/0000-0002-5097-1548
Isac, A. M.

Yates, L. L.

Barclay, W. S. https://orcid.org/0000-0002-3948-0895
Zwacka, R. M.

Bevan, C. L. https://orcid.org/0000-0002-7533-0552
Brooke, G. N. https://orcid.org/0000-0003-4501-4134
License Information

Text and Data Mining valid from 2021-07-01

Version of Record valid from 2021-07-01
More Information

Article History

Received: 9 June 2020

Accepted: 9 June 2021

First Online: 1 July 2021

Competing interests

: The authors declare no competing interests.